Latest news


Genomics plays a vital role in driving Québec's economic future. That is why Génome Québec aims at advancing knowledge in genomics by funding major research projects. In this section, you will discover all the latest achievements in the field of genomics.

Fred Sanger, the quiet giant of genomics, dies at the age of 95

Nov. 25, 2013

Génome Québec pays tribute to Fred Sanger, who died on Tuesday 19 November 2013, at the age of 95. He was the quiet giant of genomics, the father of an area of science that we will explore for decades to come.


More details...

Don't miss the next Rendez-vous Génome Québec

Nov. 12, 2013

Thursday November 14, don't miss the next Rendez-vous Génome Québec on the theme: "Improving Genomics through Collaboration and Innovation".


NGS academic and industry presentation will be featured from 8:00 AM to 4:30 PM. Lunch and coffee breaks are included and the day will conclude with a poster session and a social event with snacks and beverages.

 

For more information: http://gqinnovationcenter.com/events/rendezVous.aspx?l=e#1

 

This event will take place at the McGill University New Residence Hall
New Residence Hall, 3625 Parc Avenue, Montréal

   

More details...

New study to determine risk of Down syndrome

Nov. 4, 2013

A team of clinical researchers led by CHU de Québec and Université Laval has received CAN$10.5 million from Génome Québec, Genome Canada, CIHR, Genome Alberta and other partners to recruit 5,600 pregnant women in Canada to study the potential of using DNA sequencing alone or in a contingent model with first trimester serum markers as a non-invasive method for detecting birth defects. The four marker first trimester serum quadruple screen,1T-Quad (PAPP-A, Free beta hCG, AFP and PIGF) provided by PerkinElmer will be used by researchers to validate its use in a contingent model where women identified by the 1T-Quad screen as having an increased risk of fetal aneuploidy undergo analysis of cell-free circulating fetal DNA from a standard blood draw to better estimate their risk of Down syndrome or other trisomy.

 


More details...